Literature DB >> 11458516

RD114-pseudotyped oncoretroviral vectors. Biological and physical properties.

P F Kelly1, J Carrington, A Nathwani, E F Vanin.   

Abstract

Limited functional expression of the viral envelope receptor is a recognized barrier to efficient oncoretroviral mediated gene transfer. To circumvent this barrier we evaluated a number of envelope proteins with respect to gene transfer efficiency into primitive human hematopoietic stem cell populations. We observed that oncoretroviral vectors pseudotyped with the envelope protein of feline endogenous virus (RD114) could efficiently transduce human repopulating cells capable of establishing multilineage hematopoiesis in immunodeficient mice after a single exposure to RD114-pseudotyped vector. Comparable rates of gene transfer with amphotropic and GALV-pseudotyped vectors have been reported, but only after multiple exposures to the viral supernatant. Oncoretroviral vectors pseudotyped with the RD114 or the amphotropic envelopes had similar stability in vitro, indicating that the increased efficiency in gene transfer is at the receptor level likely due to increased receptor expression or an increased receptor affinity for the RD114 envelope. We also found that RD114-pseudotype vectors can be efficiently concentrated, thereby removing any adverse effects of the conditioned media to the long-term repopulating potential of the target human hematopoietic stem cell. These studies demonstrate the potential of RD114-pseudotyped vectors for clinical use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458516

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis.

Authors:  Gianpietro Dotti; Barbara Savoldo; Martin Pule; Karin C Straathof; Ettore Biagi; Eric Yvon; Stephane Vigouroux; Malcolm K Brenner; Cliona M Rooney
Journal:  Blood       Date:  2005-02-15       Impact factor: 22.113

2.  Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.

Authors:  Peter Ebeling; P Bach; U Sorg; A Schneider; T Trarbach; D Dilloo; H Hanenberg; S Niesert; S Seeber; T Moritz; M Flasshove
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-20       Impact factor: 4.553

3.  Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.

Authors:  Suk See Ting-De Ravin; Douglas R Kennedy; Nora Naumann; Jeffrey S Kennedy; Uimook Choi; Brian J Hartnett; Gilda F Linton; Narda L Whiting-Theobald; Peter F Moore; William Vernau; Harry L Malech; Peter J Felsburg
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

4.  Model systems for examining effects of leukemia-associated oncogenes in primary human CD34+ cells via retroviral transduction.

Authors:  Mark Wunderlich; James C Mulloy
Journal:  Methods Mol Biol       Date:  2009

5.  Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

Authors:  Biagio De Angelis; Gianpietro Dotti; Concetta Quintarelli; Leslie E Huye; Lan Zhang; Ming Zhang; Fabrizio Pane; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney; Barbara Savoldo
Journal:  Blood       Date:  2009-09-16       Impact factor: 22.113

6.  Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.

Authors:  Concetta Quintarelli; Juan F Vera; Barbara Savoldo; Greta M P Giordano Attianese; Martin Pule; Aaron E Foster; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Blood       Date:  2007-07-17       Impact factor: 22.113

7.  Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.

Authors:  Barbara Savoldo; Cliona M Rooney; Antonio Di Stasi; Hinrich Abken; Andreas Hombach; Aaron E Foster; Lan Zhang; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

8.  Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.

Authors:  Juan F Vera; Valentina Hoyos; Barbara Savoldo; Concetta Quintarelli; Greta M P Giordano Attianese; Ann M Leen; Hao Liu; Aaron E Foster; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

9.  NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.

Authors:  Robin Parihar; Charlotte Rivas; Mai Huynh; Bilal Omer; Natalia Lapteva; Leonid S Metelitsa; Stephen M Gottschalk; Cliona M Rooney
Journal:  Cancer Immunol Res       Date:  2019-01-16       Impact factor: 11.151

10.  Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics.

Authors:  Laxman Devkota; Zbigniew Starosolski; Charlotte H Rivas; Igor Stupin; Ananth Annapragada; Ketan B Ghaghada; Robin Parihar
Journal:  Sci Adv       Date:  2020-07-10       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.